| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 64309-05-3 | N-Succinimidyl 6-(4-azido-2-nitroanilino)hexanoate | C16H18N6O6 |
| 64309-07-5 | N-(4-Azido-2-Nitrophenyl)-1,2-Diaminoethane | C8H10N6O2 |
| 64309-39-3 | 2-(N,N-Dipropyl)Amino-5,6-Dihydroxytetralin | C16H25NO2 |
| 64309-42-8 | Tert-Butyloxycarbonyl-Valyl-Glycyl-Arginine-2-Naphthylamide | C28H41N7O5 |
| 64309-76-8 | 5-Aminoindazole Hydrochloride | C3H6ClN3 |
| 64310-34-5 | 1,2-Dihydro-5-(4-Methylphenyl)-3H-1,2,4-Triazole-3-Thione | C9H9N3S |
| 64312-66-9 | (1R,3S)-3-(2,2-Dimethylethenyl)-2,2-Dimethylcyclopropanecarboxylic Acid (S)-Cyano(3-Phenoxyphenyl)Methyl Ester | C24H25NO3 |
| 64312-78-3 | 2,2-Dimethyl-3-(2-Methylpropenyl)-Cyclopropanecarboxylic acid benzyl ester | C17H22O2 |
| 64312-89-6 | 3,3,3-Trifluoro-2-methoxy-2-phenylpropanoyl chloride | C10H8ClF3O2 |
| 64313-75-3 | (1S,5R,7S)-7-Ethyl-5-methyl-6,8-Dioxabicyclo[3.2.1]octane | C9H16O2 |
| 64313-94-6 | 5beta-Dihydrocortisol 21-Acetate | C23H34O6 |
| 64314-16-5 | (+)-Anatoxin A Hydrochloride | C10H16ClNO |
| 64314-28-9 | Baumycins | C34H43NO13 |
| 64314-52-9 | Medorubicin | C26H28ClNO10 |
| 64315-08-8 | 4,6-Diaziridin-1-Yl-2-(4-Methyl-2-Nitro-Phenyl)-5-Nitro-Pyrimidine | C15H14N6O4 |
| 64315-16-8 | Angiotensinogen (tetradecapeptide renin substrate) | |
| 64315-36-2 | N-[4-Hydroxy(2H4)phenyl]acetamide | C8H5D4NO2 |
| 64316-73-0 | N-Cyclohexyl-Benzenamine Hydrochloride (1:1) | C12H18ClN |
| 64317-66-4 | N-(13-Methyltetradecyl)acetamide | C17H35NO |
| 64317-75-5 | Ethyl (2E)-3-[(2-chlorophenyl)amino]-2-cyanoacrylate | C12H11ClN2O2 |
| 64317-83-5 | Lacto-N-Triose I | C20H35NO16 |
| 64318-28-1 | N-Boc-tyramine | C13H19NO3 |
| 64318-77-0 | 16,16-Dimethyl-delta2-Prostaglandin E1 | C22H36O5 |
| 64318-79-2 | Gemeprost | C23H38O5 |
| 64319-84-2 | 2-Amino-6-chloro-4-quinolinol | C9H7ClN2O |
| 64320-89-4 | 4-(Hydroxymethyl)-2-pyrrolidinone | C5H9NO2 |
| 64320-90-7 | 4-(Hydroxymethyl)-1-phenyl-2-pyrrolidinone | C11H13NO2 |
| 64320-92-9 | Methyl 5-oxo-1-phenyl-3-pyrrolidinecarboxylate | C12H13NO3 |
| 64321-24-0 | 2-Amino-6-chloronicotinamide | C6H6ClN3O |
| 64321-62-6 | 6-Isopropyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid | C13H13NO3 |
| 64321-68-2 | 4-Hydroxy-3-quinolinecarbonyl chloride | C10H6ClNO2 |
| 64321-95-5 | 3-(Trifluoromethyl)anthranilic acid methyl ester | C9H8F3NO2 |
| 64323-57-5 | 1,3,4,6,8,9b-Hexaazaphenalene | C7H4N6 |
| 64323-61-1 | 5-(1,3-Benzothiazol-2-yl)-2,4-dihydro-3H-pyrazol-3-one | C10H7N3OS |
| 64323-88-2 | Carbonic Acid 1-[2-Nitro-1-Methyl-1H-Imidazol-5-Yl]-1-Methylethyl Phenyl Ester | C14H15N3O5 |
| 64325-78-6 | N6-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyadenosine | C38H35N5O6 |
| 64326-02-9 | 4-28-Vasoactive intestinal octacosapeptide (swine) | C134H221N39O36S |
| 64328-55-8 | 4-Ethyl-Benzoic Acid Hydrazide | C9H12N2O |
| 64328-57-0 | 4-Pentylbenzohydrazide | C12H18N2O |
| 64328-60-5 | 4-Propoxy-Benzoic Acid Hydrazide | C10H14N2O2 |
| 64328-61-6 | 4-Butoxybenzohydrazide | C11H16N2O2 |
| 64328-63-8 | 4-Hexyloxy-Benzoic Acid Hydrazide | C13H20N2O2 |
| 64328-68-3 | 2-Bromo-1-(4-Pentylphenyl)-Ethanone | C13H17BrO |
| 64329-77-7 / 73608-52-3 | Pentacyclo[13.3.2.2(8,12).1(3,18).1(6,9)]tetracosa-1,3(21),6,8(23),9(24),10,12(22),15,17,19-decaene | C24H20 |
| 64330-03-6 | Aflatoxicol M1 | C17H14O7 |
| 64330-44-5 | 1-Isopropyl-1,5-dihydro-2H-pyrrol-2-one | C7H11NO |
| 64330-46-7 | 1-Benzyl-1,5-dihydro-2H-pyrrol-2-one | C11H11NO |
| 64331-48-2 | O-beta-D-Galactopyranosyl-(1→3)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→3)-O-beta-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→3)-O-beta-D-galactopyranosyl-(1→4)-D-glucose | C40H68N2O31 |
| 64332-37-2 | (4R)-6alpha-[(1S,2R)-2-Hydroxy-1-Methyl-2-(3,4,5-Trimethoxyphenyl)Ethyl]-4-Methoxy-6-(2-Propenyl)-2-Cyclohexen-1-One | C22H30O6 |
| 64332-39-4 | (4R)-6alpha-[(1S,2R)-2-(Acetyloxy)-1-Methyl-2-(7-Methoxy-1,3-Benzodioxol-5-Yl)Ethyl]-4alpha-Methoxy-6-(2-Propenyl)-2-Cyclohexen-1-One | C23H28O7 |